
Is the answer to expensive cars a pickup truck without power windows?
When
Slate
Auto, a startup, unveiled a roughly $25,000 electric pickup truck last month, social media lit up with comments. Many people saw the no-frills vehicle, with an easy-to-repair body and nostalgic hand crank windows, as a refreshing antidote to today's overstuffed and increasingly unaffordable cars.
How unaffordable? Average monthly payments on new cars have soared to $739 in March from $537 in January 2019, according to Cox Automotive. The average new car costs $47,400, with electric models around $59,200. High interest rates, now around 9.4per centfor a 72-month loan, have made cars even more of a financial stretch.
"Prices and interest rates are both high and stuck," said Mark Schirmer, director of industry insights for Cox Automotive. "If you haven't been in the market since 2018, it's got to be shocking what a car costs."
President
Donald Trump
's tariffs of 25per centon imported cars and parts have consumers scrambling to buy before prices rise even more. Cars that cost less than $30,000 are especially vulnerable -- nearly 80per centof those are subject to tariffs. They include consumer staples such as the American-made Honda Civic and Toyota Corolla, which rely on imported parts. Supplies of budget models are expected to shrink, and automakers may stop importing certain models entirely.
Enter Slate
, a company based in the Detroit suburbs backed by venture capital firms and Jeff Bezos, the Amazon founder.
Chris Barman, a former Fiat Chrysler engineer and Slate's CEO, said the Slate truck was expressly designed to ease sticker shock, although it won't be available until late 2026. The company plans to produce the pint-size truck at a retrofitted printing plant in Indiana, with a capacity for 150,000 a year.
True to its name, the truck is designed to be a blank slate to which buyers can add more than 100 accessories, like power windows and heated seats, as their budgets allow or needs change. There is no built-in stereo or touch-screen display, but there are docks for phones or tablets, saving money and avoiding the digital obsolescence that often plagues auto entertainment and navigation systems.
"We think hardworking Americans are looking for good value for the money," Barman said in a recent interview.
That message appealed to Liv Leigh, 41, who hopped inside a Slate truck during its public debut at the Long Beach Airport in California in April. Leigh, a biomedical designer and electric car enthusiast, paid $50 to reserve a Slate.
She watched the company's employees transform the two-seat pickup into a five-passenger sport utility vehicle in about one hour, with a clever conversion kit aimed at do-it-yourself owners. Leigh appreciated the truck's tidy size, shorter than a Civic, and its modest 150-mile range.
"I love the idea of an absolute base, beater truck, where I can stick a dog or muddy bikes or plywood in back," Leigh said. "I don't need a giant vehicle to haul stuff."
Barman said efficient design and production were key to the company's promised low prices. The truck's gray plastic-composite body panels eliminate any need for a steel body-stamping plant or paint shop, which can cost automakers many millions of dollars.
Where a Ford Model T, an egalitarian car of another age, famously came only in black, Slate will offer vinyl body wraps in an array of colors and styles. Buyers can also opt for a larger, factory-installed battery with a 240-mile range.
"That all keeps costs down, but also feeds into giving customers freedom of choice," Barman said. "They can outfit the vehicle the way they want it, not the way a manufacturer has designed it."
Slate hopes that a U.S.-based supply chain, including batteries made by SK On, a South Korean company, will make the pickup eligible for a $7,500 federal tax credit. Republican lawmakers on Monday released a budget bill that would eliminate that incentive and dismantle other Biden-era climate and energy policies.
That all depends on Slate's successfully navigating a treacherous path for electric vehicle startups. Several young automakers, including Fisker, Nikola and Canoo, have sought bankruptcy protection and shut down.
With or without subsidies, Slate has a viable business plan, Barman said.
The company hopes to price its truck in the mid-$20,000s before government incentives, which would undercut the Nissan Leaf, which is the most affordable electric car at $29,300 but no longer eligible for tax credits. Chevrolet plans to offer a redesigned Bolt SUV by year end for roughly $30,000. The General Motors brand intends the Bolt to qualify for the tax credit, dropping its effective price to roughly $22,500.
Erin Keating, the executive analyst of Cox Automotive, praised the Slate truck's ingenuity. But she said a pickup with two seats, short range and a bare-bones interior might not appeal to American car buyers who have grown accustomed to having many tech and creature comforts.
"There's nothing wrong with trying to crack the affordability crisis, but I don't see this as a massive volume seller," Keating said. "Ultimately, this is an extremely small EV with almost nothing in it, in a market with a growing number of affordable choices with much longer range."
As much as any vehicle category, the United States' pickup trucks epitomize how cars have changed over the past several decades, mostly by becoming bigger, more powerful and a lot more expensive. Some lavish pickups can cost as much as large European luxury sedans. Electric trucks from Tesla, Rivian and Ford range from $70,000 to more than $100,000.
Barman sees a market opening for entry-level truck fans, families shopping for a second car, empty nesters, and businesses such as landscapers, contractors and delivery workers. The company expects to sell many trucks to people who otherwise would buy a used car, the average price of which is $26,000.
One big challenge for Slate, or other companies hoping to sell more affordable cars, is that despite what they say they want, many Americans don't seem to buy such cars.
Keating noted that roughly two dozen models on the market start at less than $25,000. All are small cars or SUVs, including the market's lowest-price car, the $18,300 Nissan Versa.
Nearly every midsize family sedan starts at less than $30,000, including the Honda Accord, Toyota Camry and Hyundai Sonata. But many Americans have rejected those cars in favor of bigger vehicles. SUVs, pickups and minivans now account for more than 80per centof the market.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Mint
14 minutes ago
- Mint
Trump wants cheaper drugs like Europe has. How it works.
President Donald Trump doesn't just want to bring down prescription drug prices for Americans. He wants European countries to raise them to make up the revenue that drugmakers would lose from his policy. Trump is proposing a so-called most-favored-nation pricing model, which would set U.S. drug prices at the lowest level in other wealthy countries. But the pharmaceutical industry isn't buying into tying drug prices in the U.S. to prices in Europe—at least not knowing the details of the president's proposal. More details about the government's pricing model could come this week. On May 12, Trump directed government health officials to benchmark drug prices to international standards within 30 days. The lobbying group PhRMA, with members including U.S. pharma giants Eli Lilly, Pfizer, Johnson & Johnson, and AbbVie, has argued there are two reasons why U.S. drug prices are high: foreign countries not paying 'their fair share" for medicines, and middlemen such as pharmacy-benefit managers. Today, U.S. drug pricing is largely market driven. It involves negotiations between drug manufacturers, pharmacy-benefit managers, healthcare insurers and providers. European countries do it much differently. Each has its own way of determining drug prices, but most follow one of two broad approaches. The first approach, which Germany and France use, considers the overall clinical effectiveness of a new medicine. How does the new treatment compare to existing ones? Does it have added therapeutic benefits? If the new drug is substantially better, its price would reflect that. A second approach, used by the U.K., the Netherlands, and Sweden, analyzes cost effectiveness. This model not only compares the new drug to existing ones but also assesses the incremental value that the medicine brings to the health system. After the assessments, negotiations between drugmakers and the countries begin. Because many European countries have national health systems, they are in a strong negotiation position. If government negotiators think a medicine is too expensive for its effectiveness, they won't recommend its use. How Trump's MFN policy would work in practice isn't clear. Drug prices would probably be based on list prices in Europe since the prices paid by national health systems, or net prices, are confidential. The president's open-ended directive, laid out in an executive order, has many wondering how the U.S. could raise prices in Europe. Trump has made clear he wants to close the gap between U.S. and international prices, and has suggested he would use tariffs and export controls to achieve his goal. In theory, drugmakers could set list prices higher in Europe as long as it doesn't affect net prices, health policy expert Dr. Huseyin Naci told Barron's. In the U.K., for example, a higher list price could still lower the prices in other European countries. 'So that would still not be an acceptable approach to many other European countries," said Naci, who is associate professor of health policy at the London School of Economics. Overhauling Europe's decades-old pricing approaches would require fundamental changes to their pricing regulations—and there will be 'little appetite or ability" to alter them, Naci added. Cost is another complicating factor. 'Pharmaceutical spending is already one of the top categories of spending in many countries in terms of healthcare expenditure, so there's little room to accommodate higher prices and spending for pharmaceuticals in Europe," according to Naci. How Trump is planning to make Europeans pay more for drugs is the big question. He could use tariffs and trade negotiations as leverage. In early April, the president said a 'major" tax on pharmaceutical imports is coming 'very shortly," however nothing has been announced yet. In a trade agreement with the U.K. a month later, there is a provision on pharmaceuticals that states the U.K. will 'endeavor to improve the overall environment for pharmaceutical companies." What that means in practice still isn't clear. Write to Elsa Ohlen at


Time of India
29 minutes ago
- Time of India
US man finds snake giving ‘saucy looks' from dashboard; Mazda's hilarious 'Try Beyoncé' reply goes viral
Source: X A startling and unusual incident of a snake hiding in a vehicle's dashboard has gone viral on the social media platforms worldwide. American technology expert Simon Sarris posted that the surreal experience involved a snake sticking out of his Mazda's air-conditioning vent. His images and witty remarks went viral, eliciting a range of laughter, incredulity, and horror from users. Whereas the snake's surprise visit entertained some people, others confessed that it created a new phobia of concealed reptiles in automobiles. This unlikely encounter is a stark reminder of nature's ability to trespass across the boundaries of contemporary life. Automobiles icons of human innovation and personal territory, are not beyond the instincts of wildlife that are looking for refuge, warmth, or protection. Snake surprises US driver by peeking out from Mazda dashboard Simon Sarris went on X (formerly Twitter) to record what could only be termed a surreal experience: a snake had slithered into his luxury Mazda and was seen looking out through the air-conditioning vent. The photo he posted revealed the reptile's head protruding as if peeking around from the dashboard. Sarris captioned the photo with humour, "The snake that resides in my Mazda is giving me saucy looks this morning," inferring that the creature had taken residence. In a second post, he included, "Twenty minutes of Enya and his mood is unchanged," suggesting that even calming music hadn't persuaded the reptile to vacate. Source: X Snake in Mazda dashboard shocks the internet The post soon went viral, getting millions of views and prompting a wave of responses from readers. While some laughed at the absurdity of the incident and Sarris' collectedness, others were actually disturbed. Some users advised Sarris to sell the car, while others admitted they'd never be able to get into their vehicle again without checking every nook and cranny. 'You've just unlocked a new fear,' one user commented, reflecting the widespread sense of discomfort. Source: X Even Mazda USA was a part of the banter on the Internet. For Sarris' singing attempts, they playfully invited, "Try Beyoncé, he looks like a diva," injecting a dash of humour into the corporate account's conversation. Also Read | World Snake Day 2025 at MMNS: Touch live snakes and uncover the secrets of nature's most misunderstood creatures; know more details


Time of India
42 minutes ago
- Time of India
Trade deal lacks fine print, raising doubts over US-China truce: Shaun Rein
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel "You can have companies, the big automakers like Ford and GM are rumoured to say, we need to relocate our manufacturing to China, so we can get access to rare earths despite the heavy tariffs that they would then incur by going into the United States. But here is the thing, China's media has been a lot more circumspect with the details of this so-called trade agreement," says Shaun Rein, China Market Research is a great and big question. Trump is saying the deal has been signed and he has been talking about that the Chinese are going to send rare earths and magnets in advance to whatever the United States needs because what you have seen in the last month is the lack of rare earths that were exported to the United States has really crippled the American economy You can have companies, the big automakers like Ford and GM are rumoured to say, we need to relocate our manufacturing to China, so we can get access to rare earths despite the heavy tariffs that they would then incur by going into the United States. But here is the thing, China's media has been a lot more circumspect with the details of this so-called trade has said the rumour is that they will give maybe export licenses to rare earths on a six-month trial basis to American companies. So, basically Trump is exaggerating the win in his mind and China is being a lot more honest probably saying well we do not have all the details ironed out, we want to come to an agreement but quite frankly China has the upper hand in the trade war with the United States right that the United States makes except for semiconductors, the Chinese can buy elsewhere. So, instead of buying American beef, they are buying Australian beef; instead of buying American oil, they are buying Canadian oil; instead of buying American soybeans, they are buying Brazilian soybeans. So, what you have seen is that there is a total shift in trade patterns and a total shift in power and China is at the top of the triangle, the top of the pyramid right now in terms of buying goods and trading goods from other countries. We are seeing a shift in world order right I mean that that is not true. I mean, Chinese equity markets are up 15-16% since the start of the year while the S&P 500 is only up about 2%. So, it is quite clear that the Chinese Hong Kong equity markets are outperforming the United States right the equity markets also do not necessarily reflect the economy. So, what you are seeing right now is Abigail Johnson, who is the head of Fidelity , the rumour is today that her private investment house is going to be selling 40 Chinese tech companies that they have long held because they are worried about the regulatory and I have been talking with a lot of mutual funds, I have been talking with a lot of LPs like pension funds and endowments and they are getting huge pressure from not just Trump , but previously under the Biden regime to derisk by not investing in Chinese equities, so that does not mean the economy is bad, that just means more oppression and bullying from the United States because they are trying to really contain China's economic might have happened eight years ago and that might have worked eight years ago. But the big problem is the United States has gone after Europe. The United States has gone after Canada. You even hear Howard Lutnick, the Secretary of Commerce , criticised India last week and said, why is India buying Russian weapons, they should be buying American the reality is the United States under Trump and Biden has been bullying people all around the world. And I think at some point the global south or I prefer to call it the global majority is saying you know what, let us not deal with all the drama, let us not deal with weaponization of the US dollar, weaponization of technology and let us move closer towards China where we have a lot more stable relations with Australia for instance, Australian dollar has strengthened in the last couple weeks because basically Australia is a proxy for China. Australia's economy does well when China's economy does well, whether it be buying iron ore, whether it be buying tourists going to Australia to buy products, so that is why the Aussie has strengthened and the US dollar is weakened. Now when it comes to liquidity and volume going back towards China, we are still at a very initial of the global funds only have about 25% of their holdings exposed to China. I recommend retail investors to have 15% to 20% because of the volatility and the regulatory we are seeing in my conversations with institutional investors like hedge funds that they want to come back into China, but they have not come back yet. Now, that gives a great opportunity for speculators and people who have a high-risk appetite to trade in front of the institutional personally, I am getting more exposure to Hong Kong equities the last six months because I am trying to front run what the hedge funds are doing because they still have not quite gotten into the markets yet and they will in the next three to six months because they have to make the business case, China is outperforming the S&P the United States needs a deal. Frankly, China controls about 30-35% of global manufacturing. So, America might have the money, they might have the capital, but they need to buy the products from China. At the end of the day, China makes not just rare earths, about 90% of refined rare earths, but they also make most of the ibuprofen, most of the of the antibiotics in the world comes from China. So, at the end of the day, that is real leverage. So, for instance in 2017, 18% of Chinese exports went to the US, that number is down to 14%. China on the other hand has shifted and exports to Asean, has gone up to 16%.So, basically, it is a game of chicken right now. China's economy is hurting, do not get me wrong. There are about 15 million people who are involved in the export sector. You have seen that the CPI index has dropped about 0.1%. So, we are dealing with the D-word, the economy in China is not booming, but China is not going to blink. They have the resolve to push hard back against Trump and Scott Bessent and Howard Lutnick because at the end of the day, the Americans need to buy from China. They cannot buy antibiotics from any other country in the world except for a little bit from India.